Search research articles
Contact Us
Filters
Showing results (241-250 of 306) with videos related to
Page
of 31
Sort By:
Viruses
|
September 23, 2022
Persistent Transmission of HCV among Men Who Have Sex with Men despite Widespread Screening and Treatment with Direct-Acting Antivirals
Stephanie Popping, Lize Cuypers, Mark A A Claassen, et al.
Bulletin of the World Health Organization
|
January 28, 2026
Diagnosis of the first few cases of a novel respiratory pathogen: the FFX-Dx protocol
Claudia M Denkinger, Jane Cunningham, Verena Faehling, et al.
Clinical Chemistry and Laboratory Medicine
|
February 8, 2021
The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complications
Paul C D Bank, Leo H J Jacobs, Sjoerd A A van den Berg, et al.
International Journal of Cancer
|
May 24, 2008
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression
Inge S van Houdt, Berbel J R Sluijter, Laura M Moesbergen, et al.
BMC Infectious Diseases
|
August 15, 2015
Changes in microbiota during experimental human Rhinovirus infection
J J Hofstra, S Matamoros, M A van de Pol, et al.
Science (New York, N.Y.)
|
January 4, 2020
Absence of evidence for chiral Majorana modes in quantum anomalous Hall-superconductor devices
Morteza Kayyalha, Di Xiao, Ruoxi Zhang, et al.
Antiviral Therapy
|
May 4, 2013
Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir
R Bart Takkenberg, Louis Jansen, Annikki de Niet, et al.
Hepatology (Baltimore, Md.)
|
October 13, 2010
Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patients
Joep de Bruijne, Jilling F Bergmann, Henk W Reesink, et al.
Open Forum Infectious Diseases
|
February 22, 2021
Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study
Cas J Isfordink, Thijs J W van de Laar, Sjoerd P H Rebers, et al.
Annals of Hepatology
|
August 6, 2016
Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection
Faydra I Lieveld, Niels Swaans, Astrid M Newsum, et al.
Page
of 31
Search research articles
Search
Showing results (241-250 of 306) with videos related to
Sort By:
Page
of 31
Viruses
|
September 23, 2022
Persistent Transmission of HCV among Men Who Have Sex with Men despite Widespread Screening and Treatment with Direct-Acting Antivirals
Stephanie Popping, Lize Cuypers, Mark A A Claassen, et al.
Bulletin of the World Health Organization
|
January 28, 2026
Diagnosis of the first few cases of a novel respiratory pathogen: the FFX-Dx protocol
Claudia M Denkinger, Jane Cunningham, Verena Faehling, et al.
Clinical Chemistry and Laboratory Medicine
|
February 8, 2021
The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complications
Paul C D Bank, Leo H J Jacobs, Sjoerd A A van den Berg, et al.
International Journal of Cancer
|
May 24, 2008
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression
Inge S van Houdt, Berbel J R Sluijter, Laura M Moesbergen, et al.
BMC Infectious Diseases
|
August 15, 2015
Changes in microbiota during experimental human Rhinovirus infection
J J Hofstra, S Matamoros, M A van de Pol, et al.
Science (New York, N.Y.)
|
January 4, 2020
Absence of evidence for chiral Majorana modes in quantum anomalous Hall-superconductor devices
Morteza Kayyalha, Di Xiao, Ruoxi Zhang, et al.
Antiviral Therapy
|
May 4, 2013
Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir
R Bart Takkenberg, Louis Jansen, Annikki de Niet, et al.
Hepatology (Baltimore, Md.)
|
October 13, 2010
Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patients
Joep de Bruijne, Jilling F Bergmann, Henk W Reesink, et al.
Open Forum Infectious Diseases
|
February 22, 2021
Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study
Cas J Isfordink, Thijs J W van de Laar, Sjoerd P H Rebers, et al.
Annals of Hepatology
|
August 6, 2016
Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection
Faydra I Lieveld, Niels Swaans, Astrid M Newsum, et al.
Page
of 31